MX2018001221A - Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla. - Google Patents

Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla.

Info

Publication number
MX2018001221A
MX2018001221A MX2018001221A MX2018001221A MX2018001221A MX 2018001221 A MX2018001221 A MX 2018001221A MX 2018001221 A MX2018001221 A MX 2018001221A MX 2018001221 A MX2018001221 A MX 2018001221A MX 2018001221 A MX2018001221 A MX 2018001221A
Authority
MX
Mexico
Prior art keywords
preparing
pharmaceutical composition
same
storage stability
improved storage
Prior art date
Application number
MX2018001221A
Other languages
English (en)
Spanish (es)
Inventor
Oh Kim Bong
Chan MIN Bum
Yeong KIM Ji
Rim Kim Hye
Hyo Seo Min
Woong Yi Yil
Jin Kyung Kyu
Jeong Yoon Yoo
Original Assignee
Samyang Biopharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Biopharmaceuticals filed Critical Samyang Biopharmaceuticals
Publication of MX2018001221A publication Critical patent/MX2018001221A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
MX2018001221A 2015-07-28 2016-07-28 Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla. MX2018001221A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20150106627 2015-07-28
PCT/KR2016/008267 WO2017018818A1 (en) 2015-07-28 2016-07-28 Pharmaceutical composition with improved storage stability and method for preparing the same

Publications (1)

Publication Number Publication Date
MX2018001221A true MX2018001221A (es) 2018-04-24

Family

ID=57885186

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018001221A MX2018001221A (es) 2015-07-28 2016-07-28 Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla.

Country Status (13)

Country Link
EP (1) EP3328435A4 (ja)
JP (1) JP2018521103A (ja)
KR (1) KR101787451B1 (ja)
CN (1) CN106659681A (ja)
AU (1) AU2016299546B2 (ja)
BR (1) BR112018001725A2 (ja)
CA (1) CA2993925A1 (ja)
HK (1) HK1249442A1 (ja)
IL (1) IL257188A (ja)
MX (1) MX2018001221A (ja)
RU (1) RU2018107057A (ja)
WO (1) WO2017018818A1 (ja)
ZA (1) ZA201801188B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102144479B1 (ko) * 2018-05-24 2020-08-13 주식회사 덱스레보 조직 수복용 조성물 및 이의 제조방법
KR102251192B1 (ko) * 2020-08-07 2021-05-13 주식회사 덱스레보 조직 수복용 조성물 및 이의 제조방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7550157B2 (en) * 2000-05-12 2009-06-23 Samyang Corporation Method for the preparation of polymeric micelle via phase separation of block copolymer
US7217770B2 (en) * 2000-05-17 2007-05-15 Samyang Corporation Stable polymeric micelle-type drug composition and method for the preparation thereof
CA2463172C (en) * 2001-10-18 2009-08-18 Samyang Corporation Polymeric micelle composition with improved stability
ES2353653T3 (es) 2007-03-06 2011-03-03 Cell Therapeutics Europe S.R.L. Método para determinar la cantidad de taxano conjugado en conjugados de ácido poliglutámico-taxano.
US9801818B2 (en) * 2007-12-31 2017-10-31 Samyang Biopharmaceuticals Corporation Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug
KR101024742B1 (ko) * 2007-12-31 2011-03-24 주식회사 삼양사 탁산 함유 양친성 블록 공중합체 미셀 조성물 및 그 제조방법
BRPI0821619B1 (pt) * 2007-12-31 2018-12-18 Samyang Biopharmaceuticals método para preparação de um copolímero de bloco anfifílico
EP2201935B1 (en) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Polymeric micelle composition containing a poorly soluble drug and preparation method of the same
CN102218027B (zh) * 2011-04-22 2014-07-02 上海谊众生物技术有限公司 一种包载难溶性抗肿瘤药物的聚合物胶束冻干制剂
CN103768013A (zh) * 2014-01-17 2014-05-07 丽珠医药集团股份有限公司 以精制两亲性嵌段共聚物为载体的紫杉醇聚合物胶束

Also Published As

Publication number Publication date
KR101787451B1 (ko) 2017-10-19
HK1249442A1 (zh) 2018-11-02
BR112018001725A2 (pt) 2018-09-18
CA2993925A1 (en) 2017-02-02
EP3328435A4 (en) 2019-03-13
AU2016299546B2 (en) 2019-05-02
WO2017018818A1 (en) 2017-02-02
EP3328435A1 (en) 2018-06-06
RU2018107057A3 (ja) 2019-08-28
ZA201801188B (en) 2018-12-19
JP2018521103A (ja) 2018-08-02
IL257188A (en) 2018-03-29
CN106659681A (zh) 2017-05-10
RU2018107057A (ru) 2019-08-28
AU2016299546A1 (en) 2018-03-08
KR20170015199A (ko) 2017-02-08

Similar Documents

Publication Publication Date Title
EP3523419A4 (en) COMPOSITIONS AND METHODS FOR PRESERVING CELL VITABILITY
MY193806A (en) Affinity-oligonucleotide conjugates and uses thereof
EP3285711A4 (en) Anaerobic blood storage containers
EP3118195A4 (en) Production method for episulfide compound for optical material, episulfide-containing composition, and polymerizable composition including episulfide-containing composition and for use in optical material
IL241046A0 (en) Fertilizer composition and method for its preparation
EP3219650A4 (en) Double-weighing metering storage hopper
EP3130355A4 (en) Pharmaceutical composition containing pregabalin with improved stability and method for preparing same
EP3342414A4 (en) MEANS FOR IMPROVING ATP IN CELLS
HRP20200104T8 (hr) Novi heterociklični spoj, metoda za pripremu istog, i farmaceutska kompozicija koja sadrži isto
HK1249129A1 (zh) 用於細胞施予、保存、或培養的容器
EP3555108A4 (en) MATERIAL FOR THE STORAGE AND DELIVERY OF HYDROGEN
EP3020742A4 (en) Trioxane composition and method for storing same
MX2018001221A (es) Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla.
MX2018001219A (es) Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla.
MX2018001222A (es) Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla.
MX2018001223A (es) Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla.
AU2016905200A0 (en) Hydrogen storage and delivery material
HK1224131A2 (zh) 作能源儲存的組合物及其系統
GB2526399B (en) Battery case for lead-acid battery, lead-acid battery using the battery case, and resin composition for the battery case
AU2015901765A0 (en) Improvements in container base